Multimorbidity and polypharmacy: which betablocker to use in relation to the pharmacokinetic profile and interaction potential.
Wehling
Martin
M
Clinical Pharmacology Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. martin.wehling@medma.uni-heidelberg.de